# BioMarin Pharmaceutical, Inc. - Inspection Records

Source: https://www.keypedia.com/companies/biomarin-pharmaceutical-inc/7811b401-4321-4df1-b9b5-deef8905c101

> Inspection records and compliance data for BioMarin Pharmaceutical, Inc. in Novato, California. Access full analysis and detailed observations.

---

## Details

- Name: BioMarin Pharmaceutical, Inc.
- FEI Number: 3004079983
- City: Novato
- State: California
- Country Name: United States
- Address Line 1: 46 Galli Dr
- Zip Code: 94949

## Related Documents

- [483 - BioMarin Pharmaceutical, Inc. - Unknown Date](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/738d34c2-9e7c-4315-95b4-b0dcc2e07b20) — source: FDA, date: Invalid Date
- [FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/82d2a0af-f568-4ba0-b631-24e73e69b55a) — source: FDA, date: March 26, 2025
- [FDA Inspection 1268309 - BioMarin Pharmaceutical, Inc. - 2025-03-26](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/4cd4613e-939f-4c47-ab0f-730de2e9c32b) — classification: No Action Indicated (NAI), source: FDA, date: March 26, 2025
- [FDA Inspection 1251795 - BioMarin Pharmaceutical, Inc. - 2024-08-19](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/e8b2b049-ebee-414e-99e1-b3ba421792a2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 19, 2024
- [483 - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/f33aea76-72a2-40b2-8116-1e9d96d4c43c) — source: FDA, date: April 2, 2021
- [483 - BioMarin Pharmaceutical, Inc. - 2021-04-02](https://www.keypedia.com/records/483/biomarin-pharmaceutical-inc/68119bf5-5042-4336-9c03-7fde3f113010) — source: FDA, date: April 2, 2021
- [FDA Inspection 1041169 - BioMarin Pharmaceutical, Inc. - 2017-12-14](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/294a4562-e09d-41ef-b5da-6e26860ddf6d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2017
- [FDA Inspection 991276 - BioMarin Pharmaceutical, Inc. - 2016-11-04](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/04c426b2-4a4c-42cc-893a-c7f7b303b7d2) — classification: No Action Indicated (NAI), source: FDA, date: November 4, 2016
- [FDA Inspection 878935 - BioMarin Pharmaceutical, Inc. - 2014-04-17](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/321d151b-0d6a-4a07-8f37-0b8da6e570b6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2014
- [FDA Inspection 852996 - BioMarin Pharmaceutical, Inc. - 2013-09-24](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/7ab805bb-a1a9-4fa4-af11-6f47da4be11b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2013
- [FDA Inspection 854766 - BioMarin Pharmaceutical, Inc. - 2013-06-28](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/29eaa903-9ac8-4525-a2ca-5ffa798d4ac0) — classification: No Action Indicated (NAI), source: FDA, date: June 28, 2013
- [FDA Inspection 751754 - BioMarin Pharmaceutical, Inc. - 2011-11-03](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/f79ac3f2-8a3b-4174-b32e-bbc9d76a7902) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 3, 2011
- [FDA Inspection 671734 - BioMarin Pharmaceutical, Inc. - 2010-07-15](https://www.keypedia.com/records/fda_inspections/biomarin-pharmaceutical-inc/8cfeaed2-5bc5-4f4d-ba7a-89e088093fb0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 15, 2010

## Related Companies

- [United Therapeutics Corporation](https://www.keypedia.com/companies/united-therapeutics-corporation/c84eda64-b69f-4f0b-b5b2-67bbd708285b)
- [Norbrook Laboratories Limited](https://www.keypedia.com/companies/norbrook-laboratories-limited/c9294f28-e127-43a0-b824-82a6f41fabfd)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec)
- [Patheon Pharmaceuticals Inc.](https://www.keypedia.com/companies/patheon-pharmaceuticals-inc/f1ef6b53-3c20-4c22-9ef3-fd05fdb9f35b)
- [Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany](https://www.keypedia.com/companies/halo-pharmaceutical-inc-dba-cambrex-whippany/1464443d-ae5a-4d06-959c-d1ccb1b213a2)
- [New York Blood Center Enterprises](https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db)
- [IDT Australia Ltd.](https://www.keypedia.com/companies/idt-australia-ltd/efc89096-ddbd-47cd-be83-bfa50b1bed16)
- [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/ca77117b-0afe-4b51-bdc2-82ee1e242ec8)
- [Changzhou Pharmaceutical Factory](https://www.keypedia.com/companies/changzhou-pharmaceutical-factory/eea165e1-3df2-47c8-94b9-e8400af46bc4)
- [Minaris Regenerative Medicine, LLC](https://www.keypedia.com/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509)

## Related Officers

- [Hung H. Do](https://www.keypedia.com/people/hung-h-do/580f78ba-ed7a-4c10-8f4c-a99d0af7206e)
- [Utantini Limchumroon](https://www.keypedia.com/people/utantini-limchumroon/d1da832a-56ab-4009-829f-ed3a60835755)
- [Uttaniti Limchumroon](https://www.keypedia.com/people/uttaniti-limchumroon/ce890cbf-2f5c-498f-917c-0edf8b10d356)
- [investigator](https://www.keypedia.com/people/emmanuel-adu-gyamfi/50f014f0-f8d5-4b21-9cb0-0fdcf785edb5)
- [Kula N. Jha](https://www.keypedia.com/people/kula-n-jha/59961b64-fc92-440d-ae53-0bb03cbc9c78)